These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11858950)
1. Immunohistochemical study of membrane type-matrix metalloproteinases (MT-MMPs) and matrix metalloproteinase-2 (MMP-2) in dermatofibroma and malignant fibrous histiocytoma. Ohnishi Y; Ito Y; Tajima S; Ishibashi A; Arai K J Dermatol Sci; 2002 Feb; 28(2):119-25. PubMed ID: 11858950 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma). Weinrach DM; Wang KL; Wiley EL; Laskin WB Arch Pathol Lab Med; 2004 Oct; 128(10):1136-41. PubMed ID: 15387709 [TBL] [Abstract][Full Text] [Related]
3. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005 [TBL] [Abstract][Full Text] [Related]
4. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers. Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043 [TBL] [Abstract][Full Text] [Related]
5. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells. Ohnishi Y; Tajima S; Ishibashi A Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948 [TBL] [Abstract][Full Text] [Related]
6. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
7. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
8. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400 [TBL] [Abstract][Full Text] [Related]
9. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma. Yang HK; Jeong KC; Kim YK; Jung ST Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249 [TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
12. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Sato H; Okada Y; Seiki M Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203 [TBL] [Abstract][Full Text] [Related]
13. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424 [TBL] [Abstract][Full Text] [Related]
14. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers. Norgauer J; Hildenbrand T; Idzko M; Panther E; Bandemir E; Hartmann M; Vanscheidt W; Herouy Y Br J Dermatol; 2002 Dec; 147(6):1180-6. PubMed ID: 12452868 [TBL] [Abstract][Full Text] [Related]
15. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma. Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866 [TBL] [Abstract][Full Text] [Related]
16. Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP. Ahlén J; Enberg U; Larsson C; Larsson O; Frisk T; Brosjö O; Rosen A; Bäckdahl M Sarcoma; 2001; 5(3):143-9. PubMed ID: 18521441 [TBL] [Abstract][Full Text] [Related]
17. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S Cancer Lett; 2000 Sep; 157(2):177-84. PubMed ID: 10936678 [TBL] [Abstract][Full Text] [Related]
18. Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans. Chen YT; Chen WT; Huang WT; Wu CC; Chai CY Kaohsiung J Med Sci; 2012 Oct; 28(10):545-9. PubMed ID: 23089320 [TBL] [Abstract][Full Text] [Related]
19. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis. Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994 [TBL] [Abstract][Full Text] [Related]
20. Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Ellenrieder V; Alber B; Lacher U; Hendler SF; Menke A; Boeck W; Wagner M; Wilda M; Friess H; Büchler M; Adler G; Gress TM Int J Cancer; 2000 Jan; 85(1):14-20. PubMed ID: 10585576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]